Spontaneous and bleomycin-induced genomic alterations in the progeny of Drosophila treated males depends on the Msh2 status. DNA fingerprinting analysis.
Deficiency in DNA mismatch repair (MMR) confers instability of simple repeated sequences and increases susceptibility to cancer. Some of the MMR genes are also implicated in other repair and cellular processes related to DNA damage response. Supposedly, lack of their function can lead to a global genomic instability, besides microsatellite instability (MSI). To study the spontaneous and induced genomic instability in germ cells, related to the Msh2 status, DNA alterations in the progeny of individual crosses of Drosophila deficient in one or two copies of the Msh2 gene, were analysed by the arbitrarily primed polymerase chain reaction (AP-PCR). The results indicate that the progeny of homozygous parents for the normal Msh2 allele (+/+) presents a significantly lower frequency of genomic alterations than those from heterozygous (+/-) or mutant homozygous (-/-) parents. In addition, the DNA damage transmitted to the progeny, after the adult parental males were exposed to bleomycin, indicates that whereas the induction of mutations related to MSI depends on the lack of the Msh2 function, the induction of other mutational events may require at least one functional Msh2 allele. Thus, the results obtained with heterozygous individuals may have special relevance for cancer development since they show that a disrupted Msh2 allele is enough to generate genomic instability in germ cells, increasing the genomic damage in the progeny of heterozygous individuals. This effect is enhanced by mutagenic stress, such as occurs after bleomycin exposure.
López
A
A
Grup de Mutagènesi, Unitat de Genètica, Departament de Genètica i de Microbiologia, Edifici Cn, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Baida
A
A
Marcos
R
R
Xamena
N
N
Velázquez
A
A
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D020137:Base Pair Mismatch; D001761:Bleomycin / Q000633:toxicity*; D003433:Crosses, Genetic; D004247:DNA / Q000378:metabolism*; D004249:DNA Damage; D016172:DNA Fingerprinting; D017931:DNA Primers; D004260:DNA Repair; D029721:Drosophila Proteins; D004331:Drosophila melanogaster / Q000187:drug effects / Q000235:genetics*; D024202:Electrophoretic Mobility Shift Assay; D016678:Genome; D008297:Male; D018895:Microsatellite Repeats; D009154:Mutation / Q000235:genetics; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins; D012097:Repressor Proteins / Q000502:physiology*; D015534:Trans-Activators / Q000502:physiology*
D000964:Antimetabolites, Antineoplastic; D017931:DNA Primers; D029721:Drosophila Proteins; D011994:Recombinant Proteins; D012097:Repressor Proteins; D015534:Trans-Activators; C102933:tin protein, Drosophila; D001761:Bleomycin; D004247:DNA